Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mascaux

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Revue Des Maladies Respiratoires|November 26, 2008
[Etiology, epidemiology, biology. Lung carcinogenesis]C Mascaux
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|July 30, 2010
[Study of the genesis of bronchial epidermoid carcinoma: evolution or the expression of proteins, messenger RNAs and microRNAs at all stages of the process of carcinogenesis]C Mascaux
Seminars in Oncology|June 8, 2001
Biological basis of anemiaD Bron, N Meuleman, C Mascaux
Cytopathology : Official Journal of the British Society for Clinical Cytology|April 3, 2007
Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnosesC Garbar, C Mascaux, E Wespes
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2013
Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancerC Zielinski, S Knapp, C Mascaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Screening and early detection of lung cancerJ Vansteenkiste, C Dooms, C Mascaux, et al.
Revue Des Maladies Respiratoires|October 7, 2003
[Immune responses in broncho-pulmonary cancer]A-P Meert, T Berghmans, C Mascaux, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2006
Prognostic role of thyroid transcription factor-1 in stage III non-small cell lung cancerT Berghmans, C Mascaux, B Martin, et al.
Revue Des Maladies Respiratoires|November 16, 2019
[Therapeutic strategies in advanced ALK positive non-small cell lung cancer]A Tiotiu, Y Billon, P Vaillant, et al.
Revue Medicale De Bruxelles|July 26, 2005
[Docetaxel as salvage treatment for non-small cell lung cancer: implementation study]C Mascaux, N Iannino, T Berghmans, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Revue Des Maladies Respiratoires|November 26, 2008
[Etiology, epidemiology, biology. Lung carcinogenesis]C Mascaux
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|July 30, 2010
[Study of the genesis of bronchial epidermoid carcinoma: evolution or the expression of proteins, messenger RNAs and microRNAs at all stages of the process of carcinogenesis]C Mascaux
Seminars in Oncology|June 8, 2001
Biological basis of anemiaD Bron, N Meuleman, C Mascaux
Cytopathology : Official Journal of the British Society for Clinical Cytology|April 3, 2007
Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnosesC Garbar, C Mascaux, E Wespes
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2013
Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancerC Zielinski, S Knapp, C Mascaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Screening and early detection of lung cancerJ Vansteenkiste, C Dooms, C Mascaux, et al.
Revue Des Maladies Respiratoires|October 7, 2003
[Immune responses in broncho-pulmonary cancer]A-P Meert, T Berghmans, C Mascaux, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2006
Prognostic role of thyroid transcription factor-1 in stage III non-small cell lung cancerT Berghmans, C Mascaux, B Martin, et al.
Revue Des Maladies Respiratoires|November 16, 2019
[Therapeutic strategies in advanced ALK positive non-small cell lung cancer]A Tiotiu, Y Billon, P Vaillant, et al.
Revue Medicale De Bruxelles|July 26, 2005
[Docetaxel as salvage treatment for non-small cell lung cancer: implementation study]C Mascaux, N Iannino, T Berghmans, et al.
Pageof 5